Virologic rebound observed in 20% of patients treated with nirmatrelvir-ritonavir
An observational study of patients being treated for acute COVID-19 in a multicenter health care system observed virologic rebound in about 20% of patients treated with nirmatrelvir-ritonavir (N-R) versus about 2% of those ...
Nov 13, 2023
0
2